Quantcast
Channel: Latest Crohn's Disease News on BioPortfolio
Viewing all articles
Browse latest Browse all 2985

Protagonist raises $90M in bumpedup IPO

$
0
0
Protagonist Therapeutics Inc. NASDAQPTGX dipped $0.30 to $11.70 in its first day of trading Thursday after it raised $90 million through the sale of 7.5 million shares at $12 in an IPO. Leerink Barclays and BMO Capital Markets are underwriters.Earlier this...

Viewing all articles
Browse latest Browse all 2985

Trending Articles